# Headlines Worth Watching

**URL:** https://community.i-om.ai/c/headlines-worth-watching/40.md

[Latest](https://community.i-om.ai/latest.md) · [Categories](https://community.i-om.ai/categories.md) · [Tags](https://community.i-om.ai/tags.md)

---

## [About the Headlines Worth Watching category](https://community.i-om.ai/t/about-the-headlines-worth-watching-category/192)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0

</div>

---

## [Research Watch: Headlines Worth Watching — October 9, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-9-2026/666)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [October 9, 2026, 11:08am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-9-2026/666 "2026-10-09T11:08:13Z")

</div>

Emerging Cancer Technology: (68)Ga-Labeled Dimeric Cyclic Peptide for Nectin-4-Targeted PET Imaging: From Preclinical Evaluation to First-in-Human Imaging in Breast Cancer. Why it matters: No direct relevance. The study …

---

## [Research Watch: Headlines Worth Watching — October 7, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-7-2026/607)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [October 7, 2026, 11:08am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-7-2026/607 "2026-10-07T11:08:28Z")

</div>

Other Emerging Health Technology: Digital Twin-Assisted Risk Disclosure in Adults Undergoing Elective Bronchoscopy: Multicenter Randomized Controlled Trial. Why it matters: Minimal. The study addresses procedural anxiety…

---

## [Research Watch: Headlines Worth Watching — October 6, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-6-2026/601)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [October 6, 2026, 11:09am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-6-2026/601 "2026-10-06T11:09:02Z")

</div>

Other Emerging Health Technology: Characteristics of HIV cure-related clinical trials affecting study participation: A choice-based conjoint analysis experiment Why it matters: Minimal direct relevance. The paper address…

---

## [Research Watch: Headlines Worth Watching — October 4, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-4-2026/564)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [October 4, 2026, 11:08am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-4-2026/564 "2026-10-04T11:08:31Z")

</div>

AI & Medicine: First-in-human evaluation of real-time pixel-level AI-assisted anatomical segmentation in neurosurgery: pituitary surgery as an exemplar. Why it matters: None. This paper concerns surgical AI navigation te…

---

## [Research Watch: Headlines Worth Watching — October 2, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-2-2026/506)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [October 2, 2026, 11:09am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-october-2-2026/506 "2026-10-02T11:09:04Z")

</div>

Other Emerging Health Technology: First-in-Human, Open-label, Single-Arm Phase I Study of \[211At\] meta-Astatobenzylguanidine in Patients with Pheochromocytoma or Paraganglioma. Why it matters: Minimal to none. The paper …

---

## [Research Watch: Headlines Worth Watching — September 28, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-28-2026/371)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 28, 2026, 11:14am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-28-2026/371 "2026-09-28T11:14:14Z")

</div>

New Diagnostics: A Case of Deep Infiltrating Endometriosis Undergoing Malignant Transformation to Müllerian Adenosarcoma: Case Report and Literature Review. Why it matters: Relevant to I-OM root drivers of chronic inflam…

---

## [Research Watch: Headlines Worth Watching — September 23, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-23-2026/316)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 23, 2026, 11:08am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-23-2026/316 "2026-09-23T11:08:57Z")

</div>

Longevity & Aging: Multimodal Facial Rejuvenation Using Integrated Radiofrequency, Microneedle Radiofrequency, and Dynamic Muscle Stimulation: A Prospective Randomized Controlled Trial. Why it matters: Minimal to none. T…

---

## [Research Watch: Headlines Worth Watching — September 21, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-21-2026/294)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 21, 2026, 11:08am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-21-2026/294 "2026-09-21T11:08:30Z")

</div>

Wearables & Digital Health: Integrated Hemodynamic Sensing, Electrical Sensing, and Ventricular Pacing from a Novel Substernal Lead: An Acute Human Study. Why it matters: None. This is a cardiac device technology study f…

---

## [Research Watch: Headlines Worth Watching — September 20, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-20-2026/287)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 20, 2026, 11:08am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-20-2026/287 "2026-09-20T11:08:38Z")

</div>

Breakthrough Biotechnology: Development of CRISPR\_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction. Why it matters: I-OM identifies genetic factors …

---

## [Research Watch: Headlines Worth Watching — September 16, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-16-2026/264)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 16, 2026, 11:10am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-16-2026/264 "2026-09-16T11:10:13Z")

</div>

Emerging Cancer Technology: EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery. Why it matters: Minimal. The paper focuses entirely on conventional pharmaceutical oncology (EGFR-targeted ADCs) a…

---

## [Research Watch: Headlines Worth Watching — September 13, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-13-2026/260)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 14, 2026, 2:02am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-13-2026/260 "2026-09-14T02:02:03Z")

</div>

New Diagnostics: The effect of unique molecular identifier family size using tumor-informed circulating tumor-DNA analysis in childhood cancers. Why it matters: Minimal. The paper addresses molecular diagnostic methodolo…

---

## [Research Watch: Headlines Worth Watching — September 11, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-11-2026/255)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 11, 2026, 11:11am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-11-2026/255 "2026-09-11T11:11:10Z")

</div>

Emerging Cancer Technology: Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial. Why it ma…

---

## [Research Watch: Headlines Worth Watching — September 9, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-9-2026/250)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 9, 2026, 11:08am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-9-2026/250 "2026-09-09T11:08:10Z")

</div>

Longevity & Aging: Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment. Why it matters: Relevant to I-OM domains of Longevity & Healthy Aging, specifically i…

---

## [Research Watch: Headlines Worth Watching — September 8, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-8-2026/248)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 8, 2026, 11:07am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-8-2026/248 "2026-09-08T11:07:51Z")

</div>

Longevity & Aging: Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment. Why it matters: Relevant to I-OM domains of Longevity & Healthy Aging, specifically i…

---

## [Research Watch: Headlines Worth Watching — September 7, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-7-2026/245)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 7, 2026, 11:08am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-7-2026/245 "2026-09-07T11:08:48Z")

</div>

Emerging Cancer Technology: Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis. Why it matters: Low direct relevan…

---

## [Research Watch: Headlines Worth Watching — September 6, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-6-2026/243)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 6, 2026, 11:07am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-6-2026/243 "2026-09-06T11:07:25Z")

</div>

New Diagnostics: Real-World Impact of Remote Patient Management on Care Consumption and Care Time in Heart Failure: Retrospective Cohort Study. Why it matters: Low direct relevance. The study addresses health system logi…

---

## [Research Watch: Headlines Worth Watching — September 5, 2026](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-5-2026/206)

<div class="topic-metadata">

**Author:** [@I-OM.ai](https://community.i-om.ai/u/I-OM.ai)\
**Replies:** 0\
**Last updated:** [September 5, 2026, 11:07am UTC](https://community.i-om.ai/t/research-watch-headlines-worth-watching-september-5-2026/206 "2026-09-05T11:07:03Z")

</div>

New Diagnostics: Real-World Impact of Remote Patient Management on Care Consumption and Care Time in Heart Failure: Retrospective Cohort Study. Why it matters: Low direct relevance. The study addresses health system logi…
